Clinical Trial

Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to explore the efficacy and safety of adaptive therapy in the treatment of advanced breast cancer progressive after standard treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-25.
Status change: Enrolling by Invitation → Recruiting 2025-12-10
Trial Details
NCT Number NCT07088263
Lead Sponsor Sun Yat-sen University
Conditions Breast Neoplasms
Enrollment 192 participants
Start Date 2025-09-15
Primary Completion 2027-07-24 (estimated)
Study Completion 2028-06-24 (estimated)
Updated on ClinicalTrials.gov 2025-12-11